drugset / Trial / NCT00654017

A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis

NCT00654017

Phase 4 Completed 100 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The study was done to evaluate the efficacy, safety, and tolerability of orally administered sildenafil taken as needed about one hour before sexual activity after a 10-week period in male outpatients with erectile dysfunction and severe renal failure who were on hemodialysis.

Timeline

Start
2002-10
Primary completion
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 25 mg Oral
Comparator Sildenafil Unknown 50 mg Oral
Comparator Sildenafil Unknown 100 mg Oral

Indications